RedHill Biopharma Ltd. (RDHL) Stock Competitors & Peer Comparison

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, TAK has a market cap of 48B. Regarding current trading prices, RDHL is priced at $0.99, while TAK trades at $15.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas TAK's P/E ratio is 39.95. In terms of profitability, RDHL's ROE is +2.91%, compared to TAK's ROE of +0.03%. Regarding short-term risk, RDHL is more volatile compared to TAK. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check TAK's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, HLN has a market cap of 38.7B. Regarding current trading prices, RDHL is priced at $0.99, while HLN trades at $8.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas HLN's P/E ratio is 17.41. In terms of profitability, RDHL's ROE is +2.91%, compared to HLN's ROE of +0.17%. Regarding short-term risk, RDHL is more volatile compared to HLN. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check HLN's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, TEVA has a market cap of 38.5B. Regarding current trading prices, RDHL is priced at $0.99, while TEVA trades at $32.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas TEVA's P/E ratio is 24.69. In terms of profitability, RDHL's ROE is +2.91%, compared to TEVA's ROE of +0.21%. Regarding short-term risk, RDHL is more volatile compared to TEVA. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check TEVA's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, VTRS has a market cap of 18.3B. Regarding current trading prices, RDHL is priced at $0.99, while VTRS trades at $15.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas VTRS's P/E ratio is -52.30. In terms of profitability, RDHL's ROE is +2.91%, compared to VTRS's ROE of -0.02%. Regarding short-term risk, RDHL is more volatile compared to VTRS. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check VTRS's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, RDHL is priced at $0.99, while ITCI trades at $131.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ITCI's P/E ratio is -180.64. In terms of profitability, RDHL's ROE is +2.91%, compared to ITCI's ROE of -0.09%. Regarding short-term risk, RDHL is more volatile compared to ITCI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check ITCI's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ELAN has a market cap of 11.8B. Regarding current trading prices, RDHL is priced at $0.99, while ELAN trades at $24.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ELAN's P/E ratio is -47.31. In terms of profitability, RDHL's ROE is +2.91%, compared to ELAN's ROE of -0.04%. Regarding short-term risk, RDHL is more volatile compared to ELAN. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check ELAN's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, RDHL is priced at $0.99, while CTLT trades at $63.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas CTLT's P/E ratio is -27.84. In terms of profitability, RDHL's ROE is +2.91%, compared to CTLT's ROE of -0.25%. Regarding short-term risk, RDHL is more volatile compared to CTLT. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check CTLT's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, RGC has a market cap of 11.4B. Regarding current trading prices, RDHL is priced at $0.99, while RGC trades at $23.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas RGC's P/E ratio is -2315.00. In terms of profitability, RDHL's ROE is +2.91%, compared to RGC's ROE of -2.32%. Regarding short-term risk, RDHL is more volatile compared to RGC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check RGC's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, RDY has a market cap of 10.8B. Regarding current trading prices, RDHL is priced at $0.99, while RDY trades at $12.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas RDY's P/E ratio is 24.58. In terms of profitability, RDHL's ROE is +2.91%, compared to RDY's ROE of +0.12%. Regarding short-term risk, RDHL is more volatile compared to RDY. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check RDY's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, LNTH has a market cap of 6.3B. Regarding current trading prices, RDHL is priced at $0.99, while LNTH trades at $98.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas LNTH's P/E ratio is 22.98. In terms of profitability, RDHL's ROE is +2.91%, compared to LNTH's ROE of +0.24%. Regarding short-term risk, RDHL is more volatile compared to LNTH. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check LNTH's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, INDV has a market cap of 4.2B. Regarding current trading prices, RDHL is priced at $0.99, while INDV trades at $33.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas INDV's P/E ratio is 17.29. In terms of profitability, RDHL's ROE is +2.91%, compared to INDV's ROE of -1.42%. Regarding short-term risk, RDHL is more volatile compared to INDV. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check INDV's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, AMRX has a market cap of 4B. Regarding current trading prices, RDHL is priced at $0.99, while AMRX trades at $12.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas AMRX's P/E ratio is 34.18. In terms of profitability, RDHL's ROE is +2.91%, compared to AMRX's ROE of -1.45%. Regarding short-term risk, RDHL is more volatile compared to AMRX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check AMRX's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, SUPN has a market cap of 2.6B. Regarding current trading prices, RDHL is priced at $0.99, while SUPN trades at $44.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas SUPN's P/E ratio is -86.41. In terms of profitability, RDHL's ROE is +2.91%, compared to SUPN's ROE of -0.03%. Regarding short-term risk, RDHL is more volatile compared to SUPN. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check SUPN's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, RDHL is priced at $0.99, while DCPH trades at $25.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas DCPH's P/E ratio is -11.58. In terms of profitability, RDHL's ROE is +2.91%, compared to DCPH's ROE of -0.56%. Regarding short-term risk, RDHL is more volatile compared to DCPH. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check DCPH's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, AVDL has a market cap of 2.1B. Regarding current trading prices, RDHL is priced at $0.99, while AVDL trades at $21.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas AVDL's P/E ratio is -1082.00. In terms of profitability, RDHL's ROE is +2.91%, compared to AVDL's ROE of -0.00%. Regarding short-term risk, RDHL is more volatile compared to AVDL. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check AVDL's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, HCM has a market cap of 2B. Regarding current trading prices, RDHL is priced at $0.99, while HCM trades at $11.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas HCM's P/E ratio is 4.35. In terms of profitability, RDHL's ROE is +2.91%, compared to HCM's ROE of +0.41%. Regarding short-term risk, RDHL is more volatile compared to HCM. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check HCM's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, RDHL is priced at $0.99, while EMBCV trades at $33.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas EMBCV's P/E ratio is N/A. In terms of profitability, RDHL's ROE is +2.91%, compared to EMBCV's ROE of -0.23%. Regarding short-term risk, RDHL is less volatile compared to EMBCV. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.Check EMBCV's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, BHC has a market cap of 1.9B. Regarding current trading prices, RDHL is priced at $0.99, while BHC trades at $4.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas BHC's P/E ratio is -1.55. In terms of profitability, RDHL's ROE is +2.91%, compared to BHC's ROE of +1.21%. Regarding short-term risk, RDHL is more volatile compared to BHC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check BHC's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, DVAX has a market cap of 1.8B. Regarding current trading prices, RDHL is priced at $0.99, while DVAX trades at $15.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas DVAX's P/E ratio is -41.89. In terms of profitability, RDHL's ROE is +2.91%, compared to DVAX's ROE of -0.08%. Regarding short-term risk, RDHL is more volatile compared to DVAX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check DVAX's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ANIP has a market cap of 1.7B. Regarding current trading prices, RDHL is priced at $0.99, while ANIP trades at $75.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ANIP's P/E ratio is 19.09. In terms of profitability, RDHL's ROE is +2.91%, compared to ANIP's ROE of +0.17%. Regarding short-term risk, RDHL is more volatile compared to ANIP. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check ANIP's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, RDHL is priced at $0.99, while TARO trades at $42.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas TARO's P/E ratio is 30.05. In terms of profitability, RDHL's ROE is +2.91%, compared to TARO's ROE of +0.03%. Regarding short-term risk, RDHL is more volatile compared to TARO. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check TARO's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, PRGO has a market cap of 1.4B. Regarding current trading prices, RDHL is priced at $0.99, while PRGO trades at $10.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas PRGO's P/E ratio is -0.81. In terms of profitability, RDHL's ROE is +2.91%, compared to PRGO's ROE of -0.51%. Regarding short-term risk, RDHL is more volatile compared to PRGO. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check PRGO's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, HROW has a market cap of 1.2B. Regarding current trading prices, RDHL is priced at $0.99, while HROW trades at $33.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas HROW's P/E ratio is -86.47. In terms of profitability, RDHL's ROE is +2.91%, compared to HROW's ROE of -0.34%. Regarding short-term risk, RDHL is more volatile compared to HROW. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check HROW's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, PAHC has a market cap of 1.2B. Regarding current trading prices, RDHL is priced at $0.99, while PAHC trades at $31.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas PAHC's P/E ratio is 12.23. In terms of profitability, RDHL's ROE is +2.91%, compared to PAHC's ROE of +0.29%. Regarding short-term risk, RDHL is more volatile compared to PAHC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check PAHC's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, EVO has a market cap of 1B. Regarding current trading prices, RDHL is priced at $0.99, while EVO trades at $2.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas EVO's P/E ratio is -4.68. In terms of profitability, RDHL's ROE is +2.91%, compared to EVO's ROE of -0.24%. Regarding short-term risk, RDHL is more volatile compared to EVO. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check EVO's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, CRON has a market cap of 1B. Regarding current trading prices, RDHL is priced at $0.99, while CRON trades at $2.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas CRON's P/E ratio is -136.50. In terms of profitability, RDHL's ROE is +2.91%, compared to CRON's ROE of -0.00%. Regarding short-term risk, RDHL is more volatile compared to CRON. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check CRON's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, COLL has a market cap of 988.3M. Regarding current trading prices, RDHL is priced at $0.99, while COLL trades at $30.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas COLL's P/E ratio is 14.79. In terms of profitability, RDHL's ROE is +2.91%, compared to COLL's ROE of +0.27%. Regarding short-term risk, RDHL is more volatile compared to COLL. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check COLL's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ALVO has a market cap of 936.1M. Regarding current trading prices, RDHL is priced at $0.99, while ALVO trades at $3.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ALVO's P/E ratio is 30.00. In terms of profitability, RDHL's ROE is +2.91%, compared to ALVO's ROE of +0.35%. Regarding short-term risk, RDHL is more volatile compared to ALVO. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check ALVO's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, RDHL is priced at $0.99, while PETQ trades at $30.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas PETQ's P/E ratio is 83.73. In terms of profitability, RDHL's ROE is +2.91%, compared to PETQ's ROE of +0.01%. Regarding short-term risk, RDHL is more volatile compared to PETQ. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check PETQ's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, PCRX has a market cap of 875.2M. Regarding current trading prices, RDHL is priced at $0.99, while PCRX trades at $22.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas PCRX's P/E ratio is 171.15. In terms of profitability, RDHL's ROE is +2.91%, compared to PCRX's ROE of +0.01%. Regarding short-term risk, RDHL is more volatile compared to PCRX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check PCRX's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, AMPH has a market cap of 813.5M. Regarding current trading prices, RDHL is priced at $0.99, while AMPH trades at $18.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas AMPH's P/E ratio is 11.11. In terms of profitability, RDHL's ROE is +2.91%, compared to AMPH's ROE of +0.10%. Regarding short-term risk, RDHL is more volatile compared to AMPH. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check AMPH's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, TLRY has a market cap of 643.5M. Regarding current trading prices, RDHL is priced at $0.99, while TLRY trades at $5.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas TLRY's P/E ratio is -0.37. In terms of profitability, RDHL's ROE is +2.91%, compared to TLRY's ROE of -0.93%. Regarding short-term risk, RDHL is more volatile compared to TLRY. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check TLRY's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, RDHL is priced at $0.99, while BDSI trades at $5.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas BDSI's P/E ratio is 6.82. In terms of profitability, RDHL's ROE is +2.91%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, RDHL is more volatile compared to BDSI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check BDSI's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, IRWD has a market cap of 539.9M. Regarding current trading prices, RDHL is priced at $0.99, while IRWD trades at $3.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas IRWD's P/E ratio is 5.29. In terms of profitability, RDHL's ROE is +2.91%, compared to IRWD's ROE of -0.39%. Regarding short-term risk, RDHL is more volatile compared to IRWD. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check IRWD's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, CGC has a market cap of 451.4M. Regarding current trading prices, RDHL is priced at $0.99, while CGC trades at $1.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas CGC's P/E ratio is -0.79. In terms of profitability, RDHL's ROE is +2.91%, compared to CGC's ROE of -0.51%. Regarding short-term risk, RDHL is more volatile compared to CGC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check CGC's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, KMDA has a market cap of 433.2M. Regarding current trading prices, RDHL is priced at $0.99, while KMDA trades at $7.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas KMDA's P/E ratio is 21.46. In terms of profitability, RDHL's ROE is +2.91%, compared to KMDA's ROE of +0.08%. Regarding short-term risk, RDHL is more volatile compared to KMDA. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check KMDA's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, EOLS has a market cap of 406.3M. Regarding current trading prices, RDHL is priced at $0.99, while EOLS trades at $6.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas EOLS's P/E ratio is -9.35. In terms of profitability, RDHL's ROE is +2.91%, compared to EOLS's ROE of +1.75%. Regarding short-term risk, RDHL is more volatile compared to EOLS. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check EOLS's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, AQST has a market cap of 390.3M. Regarding current trading prices, RDHL is priced at $0.99, while AQST trades at $3.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas AQST's P/E ratio is -6.44. In terms of profitability, RDHL's ROE is +2.91%, compared to AQST's ROE of +1.91%. Regarding short-term risk, RDHL is more volatile compared to AQST. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check AQST's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, SNDL has a market cap of 373.2M. Regarding current trading prices, RDHL is priced at $0.99, while SNDL trades at $1.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas SNDL's P/E ratio is -48.00. In terms of profitability, RDHL's ROE is +2.91%, compared to SNDL's ROE of -0.01%. Regarding short-term risk, RDHL is more volatile compared to SNDL. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check SNDL's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, SIGA has a market cap of 309.8M. Regarding current trading prices, RDHL is priced at $0.99, while SIGA trades at $4.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas SIGA's P/E ratio is 15.43. In terms of profitability, RDHL's ROE is +2.91%, compared to SIGA's ROE of +0.11%. Regarding short-term risk, RDHL is more volatile compared to SIGA. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check SIGA's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, RDHL is priced at $0.99, while ALIM trades at $5.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ALIM's P/E ratio is 5.28. In terms of profitability, RDHL's ROE is +2.91%, compared to ALIM's ROE of -1.59%. Regarding short-term risk, RDHL is more volatile compared to ALIM. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check ALIM's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ORGO has a market cap of 288.2M. Regarding current trading prices, RDHL is priced at $0.99, while ORGO trades at $2.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ORGO's P/E ratio is -18.67. In terms of profitability, RDHL's ROE is +2.91%, compared to ORGO's ROE of -0.00%. Regarding short-term risk, RDHL is more volatile compared to ORGO. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check ORGO's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, TKNO has a market cap of 277.7M. Regarding current trading prices, RDHL is priced at $0.99, while TKNO trades at $5.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas TKNO's P/E ratio is -16.71. In terms of profitability, RDHL's ROE is +2.91%, compared to TKNO's ROE of -0.24%. Regarding short-term risk, RDHL is more volatile compared to TKNO. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check TKNO's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, RDHL is priced at $0.99, while LNDC trades at $8.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas LNDC's P/E ratio is -4.04. In terms of profitability, RDHL's ROE is +2.91%, compared to LNDC's ROE of -9.05%. Regarding short-term risk, RDHL is more volatile compared to LNDC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check LNDC's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, RDHL is priced at $0.99, while TYHT trades at $11.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas TYHT's P/E ratio is -1.61. In terms of profitability, RDHL's ROE is +2.91%, compared to TYHT's ROE of -0.65%. Regarding short-term risk, RDHL is more volatile compared to TYHT. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check TYHT's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, EMBC has a market cap of 207.1M. Regarding current trading prices, RDHL is priced at $0.99, while EMBC trades at $3.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas EMBC's P/E ratio is 1.85. In terms of profitability, RDHL's ROE is +2.91%, compared to EMBC's ROE of -0.17%. Regarding short-term risk, RDHL is more volatile compared to EMBC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check EMBC's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, LFCR has a market cap of 204.4M. Regarding current trading prices, RDHL is priced at $0.99, while LFCR trades at $5.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas LFCR's P/E ratio is -4.29. In terms of profitability, RDHL's ROE is +2.91%, compared to LFCR's ROE of -1.76%. Regarding short-term risk, RDHL is more volatile compared to LFCR. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check LFCR's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ACB has a market cap of 199M. Regarding current trading prices, RDHL is priced at $0.99, while ACB trades at $3.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ACB's P/E ratio is -3.25. In terms of profitability, RDHL's ROE is +2.91%, compared to ACB's ROE of -0.08%. Regarding short-term risk, RDHL is more volatile compared to ACB. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check ACB's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, RDHL is priced at $0.99, while REPH trades at $2.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas REPH's P/E ratio is -8.04. In terms of profitability, RDHL's ROE is +2.91%, compared to REPH's ROE of -0.22%. Regarding short-term risk, RDHL is more volatile compared to REPH. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check REPH's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, DERM has a market cap of 165.7M. Regarding current trading prices, RDHL is priced at $0.99, while DERM trades at $6.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas DERM's P/E ratio is -16.27. In terms of profitability, RDHL's ROE is +2.91%, compared to DERM's ROE of -0.36%. Regarding short-term risk, RDHL is more volatile compared to DERM. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check DERM's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, THTX has a market cap of 155.9M. Regarding current trading prices, RDHL is priced at $0.99, while THTX trades at $3.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas THTX's P/E ratio is -17.84. In terms of profitability, RDHL's ROE is +2.91%, compared to THTX's ROE of +0.47%. Regarding short-term risk, RDHL is more volatile compared to THTX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check THTX's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, OGI has a market cap of 153.4M. Regarding current trading prices, RDHL is priced at $0.99, while OGI trades at $1.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas OGI's P/E ratio is -7.27. In terms of profitability, RDHL's ROE is +2.91%, compared to OGI's ROE of -0.07%. Regarding short-term risk, RDHL is more volatile compared to OGI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check OGI's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ASRT has a market cap of 151.5M. Regarding current trading prices, RDHL is priced at $0.99, while ASRT trades at $23.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ASRT's P/E ratio is -4.23. In terms of profitability, RDHL's ROE is +2.91%, compared to ASRT's ROE of -0.39%. Regarding short-term risk, RDHL is more volatile compared to ASRT. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check ASRT's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, CRDL has a market cap of 128.7M. Regarding current trading prices, RDHL is priced at $0.99, while CRDL trades at $1.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas CRDL's P/E ratio is -4.11. In terms of profitability, RDHL's ROE is +2.91%, compared to CRDL's ROE of -2.29%. Regarding short-term risk, RDHL is more volatile compared to CRDL. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check CRDL's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, RDHL is priced at $0.99, while SCTL trades at $1.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas SCTL's P/E ratio is -7.86. In terms of profitability, RDHL's ROE is +2.91%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, RDHL is more volatile compared to SCTL. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check SCTL's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, PROC has a market cap of 102.1M. Regarding current trading prices, RDHL is priced at $0.99, while PROC trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas PROC's P/E ratio is 1.53. In terms of profitability, RDHL's ROE is +2.91%, compared to PROC's ROE of -2.22%. Regarding short-term risk, RDHL is more volatile compared to PROC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check PROC's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, RDHL is priced at $0.99, while OPTN trades at $9.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas OPTN's P/E ratio is -4.42. In terms of profitability, RDHL's ROE is +2.91%, compared to OPTN's ROE of +0.45%. Regarding short-term risk, RDHL is more volatile compared to OPTN. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check OPTN's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, RDHL is priced at $0.99, while ZOM trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ZOM's P/E ratio is -1.62. In terms of profitability, RDHL's ROE is +2.91%, compared to ZOM's ROE of -0.19%. Regarding short-term risk, RDHL is more volatile compared to ZOM. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check ZOM's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, RDHL is priced at $0.99, while GRVI trades at $4.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas GRVI's P/E ratio is 26.05. In terms of profitability, RDHL's ROE is +2.91%, compared to GRVI's ROE of -2.54%. Regarding short-term risk, RDHL is more volatile compared to GRVI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check GRVI's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, CPIX has a market cap of 86.5M. Regarding current trading prices, RDHL is priced at $0.99, while CPIX trades at $5.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas CPIX's P/E ratio is -11.78. In terms of profitability, RDHL's ROE is +2.91%, compared to CPIX's ROE of -0.29%. Regarding short-term risk, RDHL is more volatile compared to CPIX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check CPIX's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, RDHL is priced at $0.99, while ZYNE trades at $1.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, RDHL's ROE is +2.91%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, RDHL is more volatile compared to ZYNE. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check ZYNE's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, RDHL is priced at $0.99, while SSIC trades at $10.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas SSIC's P/E ratio is 11.93. In terms of profitability, RDHL's ROE is +2.91%, compared to SSIC's ROE of +0.00%. Regarding short-term risk, RDHL is more volatile compared to SSIC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check SSIC's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, BGM has a market cap of 65.2M. Regarding current trading prices, RDHL is priced at $0.99, while BGM trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas BGM's P/E ratio is -1.12. In terms of profitability, RDHL's ROE is +2.91%, compared to BGM's ROE of -0.03%. Regarding short-term risk, RDHL is less volatile compared to BGM. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.Check BGM's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, RDHL is priced at $0.99, while VLNS trades at $0.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas VLNS's P/E ratio is -1.03. In terms of profitability, RDHL's ROE is +2.91%, compared to VLNS's ROE of N/A. Regarding short-term risk, RDHL is more volatile compared to VLNS. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check VLNS's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, DRRX has a market cap of 59.3M. Regarding current trading prices, RDHL is priced at $0.99, while DRRX trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas DRRX's P/E ratio is -4.44. In terms of profitability, RDHL's ROE is +2.91%, compared to DRRX's ROE of +0.13%. Regarding short-term risk, RDHL is more volatile compared to DRRX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check DRRX's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, INCR has a market cap of 55.8M. Regarding current trading prices, RDHL is priced at $0.99, while INCR trades at $1.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas INCR's P/E ratio is -4.44. In terms of profitability, RDHL's ROE is +2.91%, compared to INCR's ROE of -0.09%. Regarding short-term risk, RDHL is more volatile compared to INCR. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check INCR's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ALVOW has a market cap of 51.6M. Regarding current trading prices, RDHL is priced at $0.99, while ALVOW trades at $0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ALVOW's P/E ratio is N/A. In terms of profitability, RDHL's ROE is +2.91%, compared to ALVOW's ROE of +0.35%. Regarding short-term risk, RDHL is less volatile compared to ALVOW. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.Check ALVOW's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, RDHL is priced at $0.99, while JUPW trades at $1.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas JUPW's P/E ratio is -2.41. In terms of profitability, RDHL's ROE is +2.91%, compared to JUPW's ROE of -1.94%. Regarding short-term risk, RDHL is less volatile compared to JUPW. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.Check JUPW's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, RDHL is priced at $0.99, while QLI trades at $5.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas QLI's P/E ratio is -4.92. In terms of profitability, RDHL's ROE is +2.91%, compared to QLI's ROE of -0.16%. Regarding short-term risk, RDHL is more volatile compared to QLI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check QLI's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ZYBT has a market cap of 38.2M. Regarding current trading prices, RDHL is priced at $0.99, while ZYBT trades at $0.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ZYBT's P/E ratio is -3.66. In terms of profitability, RDHL's ROE is +2.91%, compared to ZYBT's ROE of -0.26%. Regarding short-term risk, RDHL is more volatile compared to ZYBT. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check ZYBT's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, IXHL has a market cap of 35M. Regarding current trading prices, RDHL is priced at $0.99, while IXHL trades at $3.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas IXHL's P/E ratio is -0.18. In terms of profitability, RDHL's ROE is +2.91%, compared to IXHL's ROE of -1.23%. Regarding short-term risk, RDHL is more volatile compared to IXHL. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check IXHL's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, SCYX has a market cap of 32.2M. Regarding current trading prices, RDHL is priced at $0.99, while SCYX trades at $4.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas SCYX's P/E ratio is -1.33. In terms of profitability, RDHL's ROE is +2.91%, compared to SCYX's ROE of -0.57%. Regarding short-term risk, RDHL is more volatile compared to SCYX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check SCYX's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, RDHL is priced at $0.99, while HEXO trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas HEXO's P/E ratio is -0.26. In terms of profitability, RDHL's ROE is +2.91%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, RDHL is more volatile compared to HEXO. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check HEXO's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, RMTI has a market cap of 28M. Regarding current trading prices, RDHL is priced at $0.99, while RMTI trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas RMTI's P/E ratio is -4.73. In terms of profitability, RDHL's ROE is +2.91%, compared to RMTI's ROE of -0.15%. Regarding short-term risk, RDHL is more volatile compared to RMTI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check RMTI's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, TXMD has a market cap of 23.6M. Regarding current trading prices, RDHL is priced at $0.99, while TXMD trades at $2.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas TXMD's P/E ratio is 204.00. In terms of profitability, RDHL's ROE is +2.91%, compared to TXMD's ROE of +0.01%. Regarding short-term risk, RDHL is more volatile compared to TXMD. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check TXMD's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, RDHL is priced at $0.99, while CYTH trades at $0.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas CYTH's P/E ratio is -0.80. In terms of profitability, RDHL's ROE is +2.91%, compared to CYTH's ROE of -7.30%. Regarding short-term risk, RDHL is more volatile compared to CYTH. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check CYTH's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, QNTM has a market cap of 22.9M. Regarding current trading prices, RDHL is priced at $0.99, while QNTM trades at $5.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas QNTM's P/E ratio is -0.66. In terms of profitability, RDHL's ROE is +2.91%, compared to QNTM's ROE of -6.22%. Regarding short-term risk, RDHL is more volatile compared to QNTM. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check QNTM's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, OPTH has a market cap of 19.4M. Regarding current trading prices, RDHL is priced at $0.99, while OPTH trades at $5.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas OPTH's P/E ratio is -5.50. In terms of profitability, RDHL's ROE is +2.91%, compared to OPTH's ROE of -0.57%. Regarding short-term risk, RDHL is more volatile compared to OPTH. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check OPTH's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, EVOK has a market cap of 18.9M. Regarding current trading prices, RDHL is priced at $0.99, while EVOK trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas EVOK's P/E ratio is -7.97. In terms of profitability, RDHL's ROE is +2.91%, compared to EVOK's ROE of -1.01%. Regarding short-term risk, RDHL is more volatile compared to EVOK. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check EVOK's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, AYTU has a market cap of 17M. Regarding current trading prices, RDHL is priced at $0.99, while AYTU trades at $2.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas AYTU's P/E ratio is -0.46. In terms of profitability, RDHL's ROE is +2.91%, compared to AYTU's ROE of -1.49%. Regarding short-term risk, RDHL is more volatile compared to AYTU. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check AYTU's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, TLPH has a market cap of 15.9M. Regarding current trading prices, RDHL is priced at $0.99, while TLPH trades at $0.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas TLPH's P/E ratio is -2.77. In terms of profitability, RDHL's ROE is +2.91%, compared to TLPH's ROE of -0.93%. Regarding short-term risk, RDHL is more volatile compared to TLPH. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check TLPH's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, RDHL is priced at $0.99, while ACRX trades at $0.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ACRX's P/E ratio is -0.31. In terms of profitability, RDHL's ROE is +2.91%, compared to ACRX's ROE of -0.93%. Regarding short-term risk, RDHL is less volatile compared to ACRX. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.Check ACRX's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, COSM has a market cap of 14.2M. Regarding current trading prices, RDHL is priced at $0.99, while COSM trades at $0.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas COSM's P/E ratio is -0.40. In terms of profitability, RDHL's ROE is +2.91%, compared to COSM's ROE of -0.96%. Regarding short-term risk, RDHL is more volatile compared to COSM. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check COSM's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, BFRI has a market cap of 13.2M. Regarding current trading prices, RDHL is priced at $0.99, while BFRI trades at $0.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas BFRI's P/E ratio is -1.05. In terms of profitability, RDHL's ROE is +2.91%, compared to BFRI's ROE of -4.77%. Regarding short-term risk, RDHL is more volatile compared to BFRI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check BFRI's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, RDHL is priced at $0.99, while AGRX trades at $1.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas AGRX's P/E ratio is -0.89. In terms of profitability, RDHL's ROE is +2.91%, compared to AGRX's ROE of +1.32%. Regarding short-term risk, RDHL is more volatile compared to AGRX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check AGRX's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, RDHL is priced at $0.99, while NLTX trades at $3.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas NLTX's P/E ratio is -0.28. In terms of profitability, RDHL's ROE is +2.91%, compared to NLTX's ROE of -0.38%. Regarding short-term risk, RDHL is more volatile compared to NLTX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check NLTX's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, YCBD has a market cap of 7.9M. Regarding current trading prices, RDHL is priced at $0.99, while YCBD trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas YCBD's P/E ratio is 0.31. In terms of profitability, RDHL's ROE is +2.91%, compared to YCBD's ROE of -0.34%. Regarding short-term risk, RDHL is more volatile compared to YCBD. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check YCBD's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, RDHL is priced at $0.99, while LCI trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas LCI's P/E ratio is -0.04. In terms of profitability, RDHL's ROE is +2.91%, compared to LCI's ROE of +1.66%. Regarding short-term risk, RDHL is more volatile compared to LCI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check LCI's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, BGXX has a market cap of 7.3M. Regarding current trading prices, RDHL is priced at $0.99, while BGXX trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas BGXX's P/E ratio is -0.76. In terms of profitability, RDHL's ROE is +2.91%, compared to BGXX's ROE of -1.16%. Regarding short-term risk, RDHL is more volatile compared to BGXX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check BGXX's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, RDHL is priced at $0.99, while ADMP trades at $0.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ADMP's P/E ratio is -0.08. In terms of profitability, RDHL's ROE is +2.91%, compared to ADMP's ROE of -2.09%. Regarding short-term risk, RDHL is more volatile compared to ADMP. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check ADMP's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, EGRX has a market cap of 6.1M. Regarding current trading prices, RDHL is priced at $0.99, while EGRX trades at $0.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas EGRX's P/E ratio is 6.57. In terms of profitability, RDHL's ROE is +2.91%, compared to EGRX's ROE of +0.17%. Regarding short-term risk, RDHL is less volatile compared to EGRX. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.Check EGRX's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, MNK has a market cap of 4.5M. Regarding current trading prices, RDHL is priced at $0.99, while MNK trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas MNK's P/E ratio is -0.44. In terms of profitability, RDHL's ROE is +2.91%, compared to MNK's ROE of -0.26%. Regarding short-term risk, RDHL is less volatile compared to MNK. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.Check MNK's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, GELS has a market cap of 4.5M. Regarding current trading prices, RDHL is priced at $0.99, while GELS trades at $0.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas GELS's P/E ratio is -0.95. In terms of profitability, RDHL's ROE is +2.91%, compared to GELS's ROE of -0.43%. Regarding short-term risk, RDHL is more volatile compared to GELS. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check GELS's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, FLGC has a market cap of 4.2M. Regarding current trading prices, RDHL is priced at $0.99, while FLGC trades at $7.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas FLGC's P/E ratio is -0.19. In terms of profitability, RDHL's ROE is +2.91%, compared to FLGC's ROE of -0.08%. Regarding short-term risk, RDHL is less volatile compared to FLGC. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.Check FLGC's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, GHSI has a market cap of 4.2M. Regarding current trading prices, RDHL is priced at $0.99, while GHSI trades at $3.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas GHSI's P/E ratio is -0.79. In terms of profitability, RDHL's ROE is +2.91%, compared to GHSI's ROE of +0.01%. Regarding short-term risk, RDHL is more volatile compared to GHSI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check GHSI's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, CPHI has a market cap of 2.7M. Regarding current trading prices, RDHL is priced at $0.99, while CPHI trades at $0.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas CPHI's P/E ratio is -1.59. In terms of profitability, RDHL's ROE is +2.91%, compared to CPHI's ROE of -0.00%. Regarding short-term risk, RDHL is more volatile compared to CPHI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check CPHI's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, PLXP has a market cap of 2.5M. Regarding current trading prices, RDHL is priced at $0.99, while PLXP trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas PLXP's P/E ratio is -0.22. In terms of profitability, RDHL's ROE is +2.91%, compared to PLXP's ROE of -1.66%. Regarding short-term risk, RDHL is less volatile compared to PLXP. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.Check PLXP's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, ATNX has a market cap of 2.3M. Regarding current trading prices, RDHL is priced at $0.99, while ATNX trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas ATNX's P/E ratio is -0.02. In terms of profitability, RDHL's ROE is +2.91%, compared to ATNX's ROE of +0.22%. Regarding short-term risk, RDHL is more volatile compared to ATNX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.Check ATNX's competition here

RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDHL stands at 3.2M. In comparison, SNOA has a market cap of 2M. Regarding current trading prices, RDHL is priced at $0.99, while SNOA trades at $1.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDHL currently has a P/E ratio of N/A, whereas SNOA's P/E ratio is -0.59. In terms of profitability, RDHL's ROE is +2.91%, compared to SNOA's ROE of -0.86%. Regarding short-term risk, RDHL is less volatile compared to SNOA. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.Check SNOA's competition here